RPID
Rapid Micro Biosystems, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-37/100
Last price
0.96
▼ 0.02 (1.68%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.00
Prev close
0.98
Day high
1.00
Day low
0.94
Volume
162.26K
Market cap
$47.28M
P/E (TTM)
—
52W range
0.86 – 4.94
Day trading desk
Gap from prior close
+2.46%
Prior close 0.98
VWAP
0.97
-0.70% from price
Relative volume
1.21×
Normal
Session range
6.09%
0.94 – 1.00
Position in range
30%
Mid range
ATR (14D)
0.09
9.49% of price
Prior day high
1.15
PDH
Prior day low
0.91
PDL
Bid / ask spread
—
Quote not published
Session volume
330.44K
Avg 272.87K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-12.69%
-14.6%
1M
-28.02%
-29.2%
3M
-45.17%
-49.7%
6M
-56.54%
-74.7%
YTD
-67.48%
-81.7%
1Y
-75.12%
-91.5%
3Y
-12.69%
-94.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RPID open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.07M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 24, 26 | KOLLENDER RICHARD S Director |
CONVERSION | 3.51K | $2.63K | Direct |
| Jul 22, 26 | SPIGNESI ROBERT G JR Chief Executive Officer |
CONVERSION | 1.40K | $1.05K | Direct |
| May 29, 26 | WIRTJES SEAN M. CPA Chief Financial Officer |
STOCK | 12.79K | $25.00K | Direct |
| May 29, 26 | MALLOY KIRK Director |
STOCK | 12.79K | $25.00K | Direct |
| May 29, 26 | PEI MELINDA LITHERLAND Director |
STOCK | 12.79K | $25.00K | Direct |
| May 29, 26 | SPIGNESI ROBERT G JR Chief Executive Officer |
STOCK | 12.79K | $25.00K | Direct |
| May 29, 26 | LOWENSTEIN INESE Director |
STOCK | 12.79K | $25.00K | Direct |
| May 21, 26 | MALLOY KIRK Director |
STOCK | 19.30K | $0 | Direct |
| May 21, 26 | KOLLENDER RICHARD S Director |
STOCK | 19.30K | $0 | Direct |
| May 21, 26 | PEI MELINDA LITHERLAND Director |
STOCK | 19.30K | $0 | Direct |
| May 21, 26 | LOWENSTEIN INESE Director |
STOCK | 19.30K | $0 | Direct |
| May 21, 26 | BIKA DAFNI Director |
STOCK | 19.30K | $0 | Direct |
| Mar 11, 26 | WIRTJES SEAN M. CPA Chief Financial Officer |
SELL | 7.48K | $32.30K | Direct |
| Mar 11, 26 | WILSON JOHN J. ADDINGTON Chief Operating Officer |
SELL | 9.60K | $41.47K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BIKA DAFNI |
Director | 19.30K | Stock Award(Grant) |
KOLLENDER RICHARD S |
Director | 133.83K | Conversion of Exercise of derivative security |
LONGITUDE CAPITAL PARTNERS II, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LOWENSTEIN INESE |
Director | 70.69K | Stock Award(Grant) |
MALLOY KIRK |
Director | 70.69K | Stock Award(Grant) |
PEI MELINDA LITHERLAND |
Director | 100.69K | Stock Award(Grant) |
RICCIARDI NATALE S |
Director | 29.44K | Conversion of Exercise of derivative security |
SPIGNESI ROBERT G JR |
Chief Executive Officer | 1.19M | Conversion of Exercise of derivative security |
WILSON JOHN J. ADDINGTON |
Chief Operating Officer | 316.76K | Sale |
WIRTJES SEAN M. CPA |
Chief Financial Officer | 568.98K | Stock Award(Grant) |
Fundamentals
Market cap$47.28M
Enterprise value$50.26M
Revenue (TTM)$35.18M
Gross profit$1.95M
EBITDA$-47.08M
Net income$-51.20M
EPS (TTM)$-1.07
Free cash flow$-21.38M
Total cash$20.50M
Total debt$23.48M
Book value / share$0.36
Shares outstanding45.66M
Float23.91M
Short % of float3.03%
Dividend yield0.00%
Beta (5Y)1.51
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.32
PEG ratio—
Price / sales—
Price / book2.66
EV / revenue1.43
EV / EBITDA-1.07
Gross margin5.55%
Operating margin-152.99%
Profit margin-145.55%
Return on equity-141.65%
Return on assets-46.40%
Debt / equity132.29
Current ratio2.55
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $33.59M | $28.05M | $22.52M | $17.13M | +19.7% |
| Operating revenue | $33.59M | $28.05M | $22.52M | $17.13M | +19.7% |
| Cost of revenue | $32.54M | $28.16M | $28.00M | $25.67M | +15.6% |
| Gross profit | $1.05M | -$109.00K | -$5.49M | -$8.54M | +1,060.6% |
| Research & development | $13.60M | $14.60M | $12.82M | $12.87M | -6.8% |
| Selling, general & admin | $34.84M | $35.21M | $38.26M | $41.81M | -1.1% |
| Total operating expense | $48.44M | $49.81M | $51.08M | $54.68M | -2.8% |
| Operating income | -$47.39M | -$49.92M | -$56.56M | -$63.22M | +5.1% |
| Net interest income | $419.00K | $3.16M | $4.21M | $1.78M | -86.8% |
| Pre-tax income | -$47.08M | -$46.87M | -$52.44M | -$61.38M | -0.5% |
| Tax provision | $40.00K | $22.00K | $31.00K | -$576.00K | +81.8% |
| Net income | -$47.12M | -$46.89M | -$52.47M | -$60.81M | -0.5% |
| Net income to common | -$47.12M | -$46.89M | -$52.47M | -$60.81M | -0.5% |
| Basic EPS | -1.05 | -1.08 | -1.22 | -1.43 | +2.8% |
| Diluted EPS | -1.05 | -1.08 | -1.22 | -1.43 | +2.8% |
| EBIT | -$45.99M | -$46.83M | -$56.56M | -$63.22M | +1.8% |
| EBITDA | -$42.74M | -$43.47M | -$53.46M | -$60.38M | +1.7% |
| Basic shares | 44.68M | 43.58M | 43.02M | 42.45M | +2.5% |
| Diluted shares | 44.68M | 43.58M | 43.02M | 42.45M | +2.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $20.03M | $16.91M | $24.29M | $27.06M | +18.4% |
| Cash & short-term investments | $38.30M | $50.73M | $92.05M | $108.65M | -24.5% |
| Accounts receivable | $3.13M | $7.52M | $5.53M | $5.37M | -58.3% |
| Inventory | $17.59M | $20.20M | $19.96M | $21.19M | -12.9% |
| Total current assets | $61.17M | $80.92M | $120.42M | $138.58M | -24.4% |
| Property, plant & equipment | $13.08M | $16.36M | $19.07M | $20.88M | -20.0% |
| Total assets | $74.85M | $98.17M | $143.45M | $190.65M | -23.8% |
| Total current liabilities | $18.49M | $17.57M | $18.99M | $19.05M | +5.2% |
| Long-term debt | $18.90M | — | — | — | — |
| Total debt | $23.87M | $6.17M | $7.35M | $7.97M | +287.1% |
| Total liabilities | $41.65M | $22.82M | $25.46M | $26.48M | +82.5% |
| Retained earnings | -$522.40M | -$475.27M | -$428.38M | -$375.92M | -9.9% |
| Shareholder equity | $33.21M | $75.35M | $117.99M | $164.17M | -55.9% |
| Working capital | $42.68M | $63.35M | $101.43M | $119.53M | -32.6% |
| Net tangible assets | $33.21M | $75.35M | $117.99M | $164.17M | -55.9% |
| Shares issued | 44.47M | 43.04M | 42.41M | 42.09M | +3.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$47.12M | -$46.89M | -$52.47M | -$60.81M | -0.5% |
| Depreciation & amortisation | $3.25M | $3.36M | $3.10M | $2.84M | -3.3% |
| Stock-based compensation | $4.03M | $3.87M | $4.75M | $4.02M | +4.1% |
| Change in working capital | $6.06M | -$4.77M | $555.00K | -$5.33M | +227.1% |
| Operating cash flow | -$31.06M | -$44.15M | -$45.08M | -$58.55M | +29.6% |
| Capital expenditure | -$850.00K | -$1.36M | -$1.84M | -$6.74M | +37.7% |
| Investing cash flow | $14.33M | $36.66M | $42.15M | -$93.47M | -60.9% |
| Financing cash flow | $19.77M | $203.00K | $149.00K | $693.00K | +9,639.4% |
| Free cash flow | -$31.91M | -$45.52M | -$46.93M | -$65.29M | +29.9% |
| End cash position | $20.31M | $17.28M | $24.57M | $27.35M | +17.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $8.05M | $8.00M | $11.28M | $7.84M | $7.26M | +0.6% |
| Operating revenue | $8.05M | $8.00M | $11.28M | $7.84M | $7.26M | +0.6% |
| Cost of revenue | $6.84M | $7.63M | $11.61M | $7.14M | $6.99M | -10.3% |
| Gross profit | $1.21M | $371.00K | -$328.00K | $696.00K | $275.00K | +226.7% |
| Research & development | $3.33M | $3.36M | $3.22M | $3.53M | $3.23M | -0.8% |
| Selling, general & admin | $10.20M | $10.86M | $8.66M | $8.54M | $9.19M | -6.1% |
| Total operating expense | $13.53M | $14.22M | $11.88M | $12.07M | $12.42M | -4.8% |
| Operating income | -$12.32M | -$13.85M | -$12.21M | -$11.37M | -$12.15M | +11.0% |
| Net interest income | -$506.00K | -$383.00K | -$352.00K | -$46.00K | $339.00K | -32.1% |
| Pre-tax income | -$12.88M | -$14.27M | -$12.48M | -$11.50M | -$11.85M | +9.7% |
| Tax provision | $45.00K | $8.00K | $14.00K | $8.00K | $11.00K | +462.5% |
| Net income | -$12.92M | -$14.28M | -$12.50M | -$11.51M | -$11.86M | +9.5% |
| Net income to common | -$12.92M | -$14.28M | -$12.50M | -$11.51M | -$11.86M | +9.5% |
| Basic EPS | -0.27 | -0.31 | -0.28 | -0.26 | -0.27 | +12.9% |
| Diluted EPS | -0.27 | -0.31 | -0.28 | -0.26 | -0.27 | +12.9% |
| EBIT | -$12.23M | -$13.63M | -$11.81M | -$11.10M | -$11.84M | +10.2% |
| EBITDA | -$11.56M | -$12.92M | -$11.02M | -$10.30M | -$11.02M | +10.6% |
| Basic shares | 48.35M | 45.43M | 44.62M | 44.96M | 44.65M | +6.4% |
| Diluted shares | 48.35M | 45.43M | 44.62M | 44.96M | 44.65M | +6.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.69M | $13.81M | $20.03M | $18.95M | $18.33M | +6.3% |
| Cash & short-term investments | $19.77M | $22.95M | $38.30M | $41.25M | $31.25M | -13.9% |
| Accounts receivable | $5.51M | $6.37M | $3.13M | $5.43M | $6.05M | -13.4% |
| Inventory | $18.92M | $17.45M | $17.59M | $21.07M | $20.56M | +8.4% |
| Total current assets | $46.26M | $49.23M | $61.17M | $69.95M | $60.15M | -6.0% |
| Property, plant & equipment | $11.73M | $12.61M | $13.08M | $13.96M | $14.85M | -7.0% |
| Total assets | $58.45M | $62.36M | $74.85M | $84.41M | $75.59M | -6.3% |
| Total current liabilities | $18.15M | $19.12M | $18.49M | $16.55M | $16.40M | -5.1% |
| Long-term debt | $19.14M | $19.05M | $18.90M | $18.83M | — | +0.5% |
| Total debt | $23.48M | $23.71M | $23.87M | $24.11M | $5.58M | -1.0% |
| Total liabilities | $40.70M | $41.97M | $41.65M | $40.08M | $21.04M | -3.0% |
| Retained earnings | -$549.60M | -$536.67M | -$522.40M | -$509.90M | -$498.39M | -2.4% |
| Shareholder equity | $17.75M | $20.40M | $33.21M | $44.33M | $54.55M | -13.0% |
| Working capital | $28.11M | $30.11M | $42.68M | $53.40M | $43.74M | -6.6% |
| Net tangible assets | $17.75M | $20.40M | $33.21M | $44.33M | $54.55M | -13.0% |
| Shares issued | 49.97M | 45.77M | 44.47M | 44.31M | 44.06M | +9.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$12.92M | -$14.28M | -$12.50M | -$11.51M | -$11.86M | — | +9.5% |
| Depreciation & amortisation | $674.00K | $706.00K | $790.00K | $804.00K | $811.00K | — | -4.5% |
| Stock-based compensation | $1.32M | $1.22M | $627.00K | $1.15M | $1.22M | — | +8.0% |
| Change in working capital | -$2.24M | -$3.22M | $6.89M | -$28.00K | -$506.00K | — | +30.5% |
| Operating cash flow | -$12.70M | -$15.06M | -$3.25M | -$9.05M | -$9.70M | — | +15.6% |
| Capital expenditure | — | -$394.00K | -$92.00K | -$73.00K | -$366.00K | -$319.00K | — |
| Investing cash flow | $4.22M | $8.60M | $3.89M | -$9.58M | $9.34M | — | -50.9% |
| Financing cash flow | $9.35M | $247.00K | $443.00K | $19.25M | -$298.00K | — | +3,686.6% |
| Free cash flow | -$12.48M | -$15.45M | -$3.34M | -$9.12M | -$10.07M | — | +19.2% |
| End cash position | $14.97M | $14.10M | $20.31M | $19.23M | $18.62M | — | +6.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.24 | -0.27 | -11.0% |
| Mar 2026 | -0.25 | -0.31 | -25.7% |
| Dec 2025 | -0.23 | -0.28 | -23.5% |
| Sep 2025 | -0.25 | -0.26 | -6.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.20 | 4 | $9.88M | +26.0% |
| Next quarter | -0.16 | 4 | $13.34M | +18.2% |
| Current year | -0.94 | 4 | $39.28M | +17.0% |
| Next year | -0.72 | 4 | $46.32M | +17.9% |
Analyst targets & ownership
Mean target$5.75
High target$8.00
Low target$3.00
Implied upside498.96%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy0 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders10.11%
Held by institutions46.13%
Institutions holding39
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.03
-6.75% from price
SMA 20
1.09
-13.66% from price
SMA 50
1.47
-35.78% from price
SMA 100
1.69
-43.16% from price
SMA 200
2.45
-61.49% from price
EMA 12
1.04
-7.40% from price
EMA 26
1.18
-18.40% from price
EMA 50
1.38
-30.43% from price
RSI (14)
23.1
Oversold
MACD (12,26,9)
-0.14
Hist 0.00
ATR (14)
0.09
9.67% of price
Realised vol 30D
52.4%
Annualised
Bollinger upper
1.27
20, 2σ
Bollinger lower
0.91
20, 2σ
50 / 200 cross
Death
1.47 vs 2.45
Trend bias
Below 200
-61.49%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.76
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
52.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-80.3%
Peak to trough
Max drawdown 5Y
-97.3%
Peak to trough
ATR 14
0.09
9.67% of price
Beta (reported)
1.51
5Y monthly, from filing
Short interest
Shares short
940.38K
Prior 843.82K
Change vs prior
+11.4%
Shorts adding
% of float
3.03%
Normal
% of shares out
1.87%
Against total outstanding
Days to cover
4.2
Liquid
Float
23.91M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 29, 26 | Roth Capital | INITIATED | — | Buy |
| May 29, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| May 22, 26 | Lake Street | MAINTAINED | Buy | Buy |
| Jul 28, 25 | Lake Street | INITIATED | — | Buy |
| Feb 12, 25 | Keybanc | INITIATED | — | Overweight |
| Mar 7, 23 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Aug 16, 22 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| May 11, 22 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Mar 7, 22 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Feb 15, 22 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Nov 15, 21 | Morgan Stanley | MAINTAINED | — | Equal-Weight |
| Aug 9, 21 | Cowen & Co. | INITIATED | — | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-07
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-28
Periodic Financial Reports
10-Q · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-13
Proxy Statements
DEFA14A · 2026-04-08
Corporate Changes & Voting Matters
8-K · 2026-03-27
Periodic Financial Reports
10-K · 2026-03-12
Headlines
Roth Capital Partners Initiates Rapid Micro Biosystems at Buy
MT Newswires · 8d ago
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
GlobeNewswire · 32d ago
After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)
Zacks · 33d ago
Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)
Zacks · 49d ago
Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript
Motley Fool · 54d ago
Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 56d ago
Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary
Moby · 60d ago
Rapid Micro Biosystems Inc (RPID) (Q2 2026) Earnings Call Highlights: Record Revenue and ...
GuruFocus.com · 60d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.